Literature DB >> 25391313

Intradermal inactivated poliovirus vaccine: a preclinical dose-finding study.

Diana Kouiavskaia1, Olga Mirochnitchenko1, Eugenia Dragunsky1, Efrat Kochba2, Yotam Levin2, Stephanie Troy3, Konstantin Chumakov1.   

Abstract

Intradermal delivery of vaccines has been shown to result in dose sparing. We tested the ability of fractional doses of inactivated poliovirus vaccine (IPV) delivered intradermally to induce levels of serum poliovirus-neutralizing antibodies similar to immunization through the intramuscular route. Immunogenicity of fractional doses of IPV was studied by comparing intramuscular and intradermal immunization of Wistar rats using NanoPass MicronJet600 microneedles. Intradermal delivery of partial vaccine doses induced antibodies at titers comparable to those after immunization with full human dose delivered intramuscularly. The results suggest that intradermal delivery of IPV may lead to dose-sparing effect and reduction of the vaccination cost. Published by Oxford University Press on behalf of the Infectious Diseases Society of America 2014. This work is written by (a) US Government employee(s) and is in the public domain in the US.

Entities:  

Keywords:  dose sparing; immunogenicity; inactivated poliovirus vaccine; intradermal

Mesh：

Substances：

Year:  2014        PMID： 25391313      PMCID： PMC4462654          DOI： 10.1093/infdis/jiu624

Source DB:  PubMed          Journal:  J Infect Dis        ISSN： 0022-1899            Impact factor:   5.226


  11 in total

Review 1.  Intradermal fractional dose inactivated polio vaccine: a review of the literature.

Authors:  Katherine S Nelson; Julia M Janssen; Stephanie B Troy; Yvonne Maldonado
Journal:  Vaccine       Date:  2011-11-17       Impact factor: 3.641

Review 2.  Vaccine-derived polioviruses and the endgame strategy for global polio eradication.

Authors:  Olen M Kew; Roland W Sutter; Esther M de Gourville; Walter R Dowdle; Mark A Pallansch
Journal:  Annu Rev Microbiol       Date:  2005       Impact factor: 15.500

3.  Randomized trial of inactivated and live polio vaccine schedules in Guatemalan infants.

Authors:  Edwin J Asturias; Erica L Dueger; Saad B Omer; Arturo Melville; Silvia V Nates; Majid Laassri; Konstantin Chumakov; Neal A Halsey
Journal:  J Infect Dis       Date:  2007-07-23       Impact factor: 5.226

Review 4.  Vaccine-derived poliovirus from long term excretors and the end game of polio eradication.

Authors:  Javier Martín
Journal:  Biologicals       Date:  2006-05-02       Impact factor: 1.856

5.  Meeting of the Strategic Advisory Group of Experts on immunization, April 2012--conclusions and recommendations.

Authors: 
Journal:  Wkly Epidemiol Rec       Date:  2012-05-25

6.  Intradermal fractional booster dose of inactivated poliomyelitis vaccine with a jet injector in healthy adults.

Authors:  Darius Soonawala; Pauline Verdijk; Alienke J Wijmenga-Monsuur; Claire J Boog; Patrick Koedam; Leo G Visser; Nynke Y Rots
Journal:  Vaccine       Date:  2013-06-13       Impact factor: 3.641

7.  Dose sparing intradermal trivalent influenza (2010/2011) vaccination overcomes reduced immunogenicity of the 2009 H1N1 strain.

Authors:  Ivan F N Hung; Yotam Levin; Kelvin K W To; Kwok-Hung Chan; Anna Jinxia Zhang; Patrick Li; Clara Li; Ting Xu; Tin-Yan Wong; Kwok-Yung Yuen
Journal:  Vaccine       Date:  2012-08-18       Impact factor: 3.641

8.  Implications of a circulating vaccine-derived poliovirus in Nigeria.

Authors:  Helen E Jenkins; R Bruce Aylward; Alex Gasasira; Christl A Donnelly; Michael Mwanza; Jukka Corander; Sandra Garnier; Claire Chauvin; Emmanuel Abanida; Muhammad Ali Pate; Festus Adu; Marycelin Baba; Nicholas C Grassly
Journal:  N Engl J Med       Date:  2010-06-24       Impact factor: 91.245

9.  Randomized controlled study of fractional doses of inactivated poliovirus vaccine administered intradermally with a needle in the Philippines.

Authors:  Josefina Cadorna-Carlos; Emmanuel Vidor; Marie-Claude Bonnet
Journal:  Int J Infect Dis       Date:  2011-12-05       Impact factor: 3.623

10.  Echographic measurement of skin thickness in adults by high frequency ultrasound to assess the appropriate microneedle length for intradermal delivery of vaccines.

Authors:  Aurélie Laurent; Frédéric Mistretta; David Bottigioli; Karima Dahel; Catherine Goujon; Jean François Nicolas; Anca Hennino; Philippe E Laurent
Journal:  Vaccine       Date:  2007-06-11       Impact factor: 3.641
View more
  3 in total

1.  Comparison of the Immunogenicity of Various Booster Doses of Inactivated Polio Vaccine Delivered Intradermally Versus Intramuscularly to HIV-Infected Adults.

Authors:  Stephanie B Troy; Diana Kouiavskaia; Julia Siik; Efrat Kochba; Hind Beydoun; Olga Mirochnitchenko; Yotam Levin; Nancy Khardori; Konstantin Chumakov; Yvonne Maldonado
Journal:  J Infect Dis       Date:  2015-01-07       Impact factor: 5.226

2.  Analyzed immunogenicity of fractional doses of Sabin-inactivated poliovirus vaccine (sIPV) with intradermal delivery in rats.

Authors:  Lei Ma; Wei Cai; Mingbo Sun; Yina Cun; Jian Zhou; Jing Liu; Wenzhu Hu; Xinwen Zhang; Shaohui Song; Shude Jiang; Guoyang Liao
Journal:  Hum Vaccin Immunother       Date:  2016-08-15       Impact factor: 3.452

3.  Determination of Depth-Dependent Intradermal Immunogenicity of Adjuvanted Inactivated Polio Vaccine Delivered by Microinjections via Hollow Microneedles.

Authors:  Pim Schipper; Koen van der Maaden; Stefan Romeijn; Cees Oomens; Gideon Kersten; Wim Jiskoot; Joke Bouwstra
Journal:  Pharm Res       Date:  2016-06-17       Impact factor: 4.200
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.